Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : The Atorvastatin\/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics - Jones_2008_Alzheimers.Dement_4_145 |
| Author(s) : Jones RW , Kivipelto M , Feldman H , Sparks L , Doody R , Waters DD , Hey-Hadavi J , Breazna A , Schindler RJ , Ramos H |
| Ref : Alzheimers Dement , 4 :145 , 2008 |
| Abstract : Jones_2008_Alzheimers.Dement_4_145 |
| ESTHER : Jones_2008_Alzheimers.Dement_4_145 |
| PubMedSearch : Jones_2008_Alzheimers.Dement_4_145 |
| PubMedID: 18631958 |
| Title : Poster (46) Major hallmarks in alzheimer's disease (ad) can beneficially be modulated by M1 muscarinic agonists - an added value vs. cholinesterase inhibitors - |
| Author(s) : Fisher A , Brandeis R , Pittel Z , Haring R , Sparks L , Beach TG , Bons N , Maestre-Frances N , Bar-Ner N , Kliger-Spatz M , Natan N , Marcovitch I , Hartmann T |
| Ref : In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects , (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina :345 , 2004 |
| PubMedID: |